# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007632
Filing Date
2024-05-09
Accepted
2024-05-09 16:31:01
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | glyc-20240331x10q.htm iXBRL | 10-Q | 992582
2 | EX-31.1 | glyc-20240331xex31d1.htm | EX-31.1 | 16950
3 | EX-31.2 | glyc-20240331xex31d2.htm | EX-31.2 | 16766
4 | EX-32.1 | glyc-20240331xex32d1.htm | EX-32.1 | 9429
| Complete submission text file | 0001558370-24-007632.txt |  | 4855538

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | glyc-20240331.xsd | EX-101.SCH | 37318
6 | EX-101.CAL | glyc-20240331_cal.xml | EX-101.CAL | 33380
7 | EX-101.DEF | glyc-20240331_def.xml | EX-101.DEF | 177969
8 | EX-101.LAB | glyc-20240331_lab.xml | EX-101.LAB | 359441
9 | EX-101.PRE | glyc-20240331_pre.xml | EX-101.PRE | 305295
69 | EXTRACTED XBRL INSTANCE DOCUMENT | glyc-20240331x10q_htm.xml | XML | 662301

Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 24931251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)